Video Experimental Relacionado
Updated: Jul 10, 2026
09:10
Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Síntesis total y propiedades antibacterianas de la carbaplatensimicina
K C Nicolaou1, Yefeng Tang, Jianhua Wang
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. kcn@scripps.edu
Journal of the American Chemical Society
|November 9, 2007
Resumen
La carbaplatensimicina, un análogo de carbono de la platensimicina, ha sido sintetizada y evaluada biológicamente. Este nuevo antibiótico muestra una potencia antibacteriana comparable contra las cepas resistentes, incluidas las bacterias resistentes a la meticilina y la vancomicina.
Área de la Ciencia:
- Química Medicinal La Química Medicinal es un campo de estudio de la química medicinal.
- Microbiología Microbiología.
- Química orgánica sintética y orgánica.
Sus antecedentes:
- La platensimicina es un antibiótico recientemente reportado con actividad antibacteriana significativa.
- El desarrollo de nuevos antibióticos es crucial para combatir la creciente resistencia a los antimicrobianos.
Objetivo del estudio:
- Para lograr la síntesis química de la carbaplatensimicina, el análogo de carbono de la platensimicina.
- Para evaluar la actividad biológica de la carbaplatensimicina como agente antibacteriano.
Principales métodos:
- Síntesis química de la carbaplatensimicina. también conocida como carbaplatensimicina.
- Pruebas antibacterianas in vitro contra varias cepas de bacterias.
Principales resultados:
- La carbaplatensimicina fue sintetizada con éxito.
- La carbaplatensimicina demostró una potente actividad antibacteriana, comparable a la de la platensimicina.
- Se observó actividad contra el Staphylococcus aureus resistente a la meticilina (MRSA) y los enterococos resistentes a la vancomicina (ERV).
Conclusiones:
- La carbaplatensimicina es un análogo de carbono viable de la platensimicina.
- Este antibiótico sintético es prometedor para el tratamiento de infecciones causadas por bacterias resistentes.
Videos de Conceptos Relacionados
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...